Michael T. Cullen
2019
In 2019, Michael T. Cullen earned a total compensation of $659.8K as Executive Chairman at Panbela Therapeutics.
Compensation breakdown
| Option Awards | $377,471 |
|---|---|
| Salary | $282,350 |
| Total | $659,821 |
Cullen received $377.5K in option awards, accounting for 57% of the total pay in 2019.
Cullen also received $282.4K in salary.
Rankings
In 2019, Michael T. Cullen's compensation ranked 10,914th out of 13,971 executives tracked by ExecPay. In other words, Cullen earned more than 21.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,914 out of 13,971 | 22nd |
Division Manufacturing | 4,414 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,725 out of 2,200 | 22nd |
Industry group Drugs | 1,479 out of 1,886 | 22nd |
Industry Pharmaceutical Preparations | 1,090 out of 1,398 | 22nd |
Source: SEC filing on April 15, 2021.
Cullen's colleagues
We found one more compensation record of an executive who worked with Michael T. Cullen at Panbela Therapeutics in 2019.
2019
Susan Horvath
Panbela Therapeutics